Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Velcade: MLNM began an open-label international Phase III trial comparing Velcade for injection to high dose dexamethasone in 600 MM patients whose disease has

Millennium Pharmaceuticals Inc. (MLNM), Cambridge, Mass.
Product: Velcade

Read the full 86 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE